XML 43 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets (Details) - USD ($)
 3 Months Ended
Mar. 11, 2024
Aug. 15, 2023
Mar. 31, 2024
Intangible Assets      
Accrual for intangible asset milestone obligations     $ 4,000,000
License | Formosa Pharmaceuticals Inc      
Intangible Assets      
Percentage of product approved by FDA   0.05%  
Upfront payment   $ 2,000,000.0  
Upfront payment paid in cash   $ 1,000,000.0  
Issuance of common stock as consideration for licensing agreement (in shares)   487,805  
Issuance of common stock as consideration for licensing agreement   $ 1,000,000.0  
Legal expenses capitalized   122,945  
Maximum amount payable upon achievement of certain sales milestones   $ 80,000,000.0  
Initial development milestone payment which trigger FDA approval $ 2,000,000.0   2,000,000.0
License agreement payment period 45 days    
Accrual for intangible asset milestone obligations     $ 2,000,000.0